Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation

Author： Bubela Tania   Reshef Amir   Li Matthew D   Atkins Harold   Caulfield Timothy   Culme-Seymour Emily   Gold E Richard   Illes Judy   Isasi Rosario   McCabe Christopher   Ogbogu Ubaka   Piret James   Mason Chris  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.20, Iss.20, 2012-11, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interview: Commercial translation of cell-based therapies and regenerative medicine: learning by experience

By Haseltine William A  

Regenerative Medicine, Vol. 6, Iss. 4, 2011-07 ,pp. : 431-435

Future Medicine

Access to resources Recommend Favorite

Integration and translation: driving stem cell therapies toward the clinic

By Trounson Alan  

Regenerative Medicine, Vol. 3, Iss. 3, 2008-05 ,pp. : 269-273

Future Medicine

Access to resources Recommend Favorite

Maintenance therapies in advanced non-small-cell lung cancer

By Lebovic Daniel J   Chiappori Alberto   Gray Jhanelle  

Therapy, Vol. 8, Iss. 1, 2011-01 ,pp. : 33-41

Future Medicine

Access to resources Recommend Favorite

Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?

By Squassina Alessio   Pisanu Claudia  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 765-768

Future Medicine

Access to resources Recommend Favorite

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite